decrease font sizeDecrease text size


A knowledge-based enterprise since formation, Interpath has invested heavily in research and development of their joint nutraceutical products, which have resulted in ground breaking results in the research of cellular and tissue inflammation including degenerative joint disease (DJD).


Interpath has utilised the latest molecular and cellular biology techniques and technologies, with in-vivo and in-vitro studies providing unequivocal understanding of the science behind their signature products.   



4CYTE Canine launched in Australia
4CYTE canine has arrived in Australia, now available from your vet.
More News...

Interpath Global Positioning


All Content © 2019 Interpath - Website by CeRDI  | Intellectual Property | Sitemap